CN Patent
CN119101036A — 喹喔啉类化合物及其应用
Assigned to Beike Huaxia Biomedical Technology Co ltd · Expires 2024-12-10 · 1y expired
What this patent protects
本申请涉及一种喹喔啉类化合物及其应用。所述喹喔啉类化合物具有如下式(1)所示结构特征。该喹喔啉类化合物具有良好的DDR1和/或DDR2受体抑制活性。
USPTO Abstract
本申请涉及一种喹喔啉类化合物及其应用。所述喹喔啉类化合物具有如下式(1)所示结构特征。该喹喔啉类化合物具有良好的DDR1和/或DDR2受体抑制活性。
Drugs covered by this patent
- Balversa (ERDAFITINIB) · Johnson & Johnson
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.